Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.
about
Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemiaCardiac Structural and Functional Changes Evaluated by Transthoracic and Tissue Doppler Echocardiography in Adult Patients with Sickle Cell Disease.Left ventricular myocardial performance assessed by 2-dimensional speckle tracking echocardiography in patients with sickle cell crisisEchocardiographic evaluation of left ventricular diastolic and systolic function in Saudi patients with sickle cell disease.Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.Segmentation and quantification of pulmonary artery for noninvasive CT assessment of sickle cell secondary pulmonary hypertension.Computed tomography correlates with cardiopulmonary hemodynamics in pulmonary hypertension in adults with sickle cell disease.Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation.NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in AfricaExercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia.Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review.Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron deposition.Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsHeart rate recovery is impaired after maximal exercise testing in children with sickle cell anemia.Mechanistic insights and characterization of sickle cell disease-associated cardiomyopathyNon-congenital heart disease associated pediatric pulmonary arterial hypertensionEchocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network reportProspective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease.Abnormalities in cardiac structure and function in adults with sickle cell disease are not associated with pulmonary hypertension.Increased pulmonary pressures and myocardial wall stress in children with severe malariaPulmonary artery pressure and iron deficiency in patients with upregulation of hypoxia sensing due to homozygous VHL(R200W) mutation (Chuvash polycythemia).Correlation of N-terminal fragment of B-type natriuretic peptide levels with clinical, laboratory, and echocardiographic abnormalities in children with sickle cell disease.Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiencyPulmonary hypertension in sickle cell disease: relevance to children.Genome-Wide Analysis Identifies IL-18 and FUCA2 as Novel Genes Associated with Diastolic Function in African Americans with Sickle Cell DiseasePrevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria.Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension.Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease.Pathophysiology and treatment of pulmonary hypertension in sickle cell diseaseMyocardial infarction in sickle cell disease: use of translational imaging to diagnose an under-recognized problemCardiomyopathy With Restrictive Physiology in Sickle Cell DiseaseEvaluation of myocardial deformation in patients with sickle cell disease and preserved ejection fraction using three-dimensional speckle tracking echocardiographyReduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidinMinireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication.Hemodynamic predictors of mortality in adults with sickle cell diseaseSickle cell anemia-associated pulmonary arterial hypertension.
P2860
Q28395387-E370C64F-627C-4187-A6C1-F45C229EA77FQ30357012-F3581808-9728-4546-AAD4-E2AB35FF1C0BQ30444419-AED6AA55-10D1-4A9D-820D-4983A0E09322Q30447935-16E57965-6111-4B81-A2EA-7DFB16C0B817Q30945205-FBCB3AA9-45D0-4A98-8607-EE5CF2516023Q33766843-07B45E85-9DD4-4AA3-B176-DB795D7CC339Q33805998-4538B73A-6885-46A3-A207-B779C5A6115BQ33899415-BF707B13-38D4-4DE8-AA3D-A656E9B43941Q33997200-DC828D8A-1252-4FE1-897C-AB28B8F50FEAQ34009129-379C92A6-A2C2-4B47-91C8-A4D1AE7052D5Q34038886-E22B1994-1B70-4DBD-9151-92B8E86D5ECBQ34451512-D95BB9CB-26A2-4526-88E4-22E7900EA5A9Q34470834-1950173D-A7F9-492D-8A90-5703E533F745Q34786236-45C841A6-4CAE-4649-94BA-25460CA8AE39Q34898802-96E51FF9-CE76-424B-8694-8539124F6B3AQ34992760-A87F6FE0-9D8C-4A70-ABC4-C87E2307DFFEQ35019607-48C60E6D-0295-409F-A7C7-AA0F1FA84ADFQ35078958-9AEA166A-3A19-4FD5-905D-EDDABBD22C77Q35165691-6C2D6401-F95B-48BE-82EC-797BA263C26EQ35243386-02ADC114-18CB-4466-919B-92D7359EADD4Q35346284-ED7ED299-1FD2-4ED4-8D8F-B2D4F8A3FEC0Q35399728-94E6901F-E58D-4C96-9A22-B65618F013B2Q35435386-C7A2FA5F-CD66-4DB7-9639-0B0C9DD124B8Q35508081-6ED8079F-20FC-4331-AAF4-AA86D5ACC2AEQ35717769-8F38AECF-7C0C-4346-B85E-1EB042A8DDDCQ35742699-25E95171-5F60-485C-8F9C-5B6209CB1608Q36100581-0F942CA8-41AA-4137-A8DA-DF772D8056A1Q36120873-86563F19-2A22-4DFE-943F-B0979F0EE9BCQ36135607-201D7A45-9180-4728-B360-0B43746E33FEQ36152191-1DBEFD4F-A965-423E-A550-7FCC6F7328B8Q36330543-FCE6E6DB-8443-4393-B367-9169EAAB59ADQ36384658-B26A1B09-C05C-4AD2-B203-168250AF3F61Q36596861-34DA19E0-7DA8-4010-9F6B-FF13F5FACF15Q36673817-1F523D77-38A5-445C-AD31-DA2E9E93B30CQ36677950-22197053-68AE-45B2-81DC-ECDB70DF2D3EQ36739863-79D9A7FD-2D59-4284-8F94-992F575C35CBQ36862359-FB80D931-0FEB-4093-AA30-337C541A7F19Q36913577-CE76D2FD-EE22-4970-8E09-9417CBC21ADAQ36999803-CBC85C7B-2C03-44FF-ACDE-621CBE12597EQ37008399-9EBA6DDD-364F-421D-BCD3-2A7DC110DD9A
P2860
Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Diastolic dysfunction is an in ...... ents with sickle cell disease.
@ast
Diastolic dysfunction is an in ...... ents with sickle cell disease.
@en
type
label
Diastolic dysfunction is an in ...... ents with sickle cell disease.
@ast
Diastolic dysfunction is an in ...... ents with sickle cell disease.
@en
prefLabel
Diastolic dysfunction is an in ...... ents with sickle cell disease.
@ast
Diastolic dysfunction is an in ...... ents with sickle cell disease.
@en
P2093
P2860
P921
P1476
Diastolic dysfunction is an in ...... ents with sickle cell disease.
@en
P2093
Douglas R Rosing
Inez Ernst
Marilyn St Peter
Oswaldo Castro
Roberto F Machado
Stanislav Sidenko
Vandana Sachdev
William C Blackwelder
Wynona A Coles
Yesoda N Rao
P2860
P304
P356
10.1016/J.JACC.2006.09.038
P407
P577
2007-01-16T00:00:00Z